DICOT — Dicot Pharma AB Share Price
0.000.00%
Last trade - 00:00- SEK611.90m
- SEK498.48m
- SEK0.03m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.48 | ||
| Price to Tang. Book | 5.48 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 23,534.63 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -53.06% | ||
| Return on Equity | -73.94% | ||
| Operating Margin | -227896.15% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 0.02 | 0.08 | 0.12 | 0.23 | 0.03 | n/a | n/a | -47.16% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Dicot Pharma AB, formerly known as Dicot AB is Sweden- based drug pharmaceutical company primarily engaged in the drug development industry. The Company scope of activity revolves around developing innovations that enhance sexual health. The company develops and manufactures medicines for the treatment of erectile dysfunction and premature ejaculation. The company's lead candidate is LIB-01 which is in the clinical testing. The Company conducted comprehensive preclinical studies, verifying LIB-01’s effect across multiple studies. The active substance in LIB-01 is a semi-synthetically produced molecule based on a folk medicine use. Dicot Pharma AB goal is to develop a completely new generation of potency drugs.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 5th, 2015
- Public Since
- June 20th, 2018
- No. of Employees
- 3
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 1,778,779,842
- Address
- S:t Olofsgatan 11A, Uppsala, 753 21
- Web
- https://www.dicotpharma.com/
- Phone
- Auditors
- PWC
Upcoming Events for DICOT
Dicot AB Annual Shareholders Meeting
Similar to DICOT
Biogaia AB
OMX Nordic Exchange Stockholm
BoneSupport Holding AB
OMX Nordic Exchange Stockholm
Camurus AB
OMX Nordic Exchange Stockholm
Cinclus Pharma Holding publ AB
OMX Nordic Exchange Stockholm
Corline Biomedical AB
OMX Nordic Exchange Stockholm
FAQ
What is the Dicot Pharma AB share price?
As of Today at 20:15 UTC, shares in Dicot Pharma AB are trading at SEK0.34. This share price information is delayed by 15 minutes.
How has the Dicot Pharma AB share price performed this year?
Shares in Dicot Pharma AB last closed at SEK0.34 and the price had moved by +88.22% over the past 365 days. In terms of relative price strength the Dicot Pharma AB share price has outperformed the FTSE Global All Cap Index by +83.51% over the past year.
What are the analyst and broker recommendations for Dicot Pharma AB?
There is no consensus recommendation for this security.
Find out moreWhat is the Dicot Pharma AB dividend yield?
Dicot Pharma AB does not currently pay a dividend.
Does Dicot Pharma AB pay a dividend?
Dicot Pharma AB does not currently pay a dividend.
When does Dicot Pharma AB next pay dividends?
Dicot Pharma AB does not currently pay a dividend.
How do I buy Dicot Pharma AB shares?
To buy shares in Dicot Pharma AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Dicot Pharma AB?
As of the previous close price of SEK0.34, shares in Dicot Pharma AB had a market capitalisation of SEK611.90m.
Where are Dicot Pharma AB shares listed?
Here are the trading details for Dicot Pharma AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: DICOT
What kind of share is Dicot Pharma AB?
Based on an overall assessment of its quality, value and momentum Dicot Pharma AB is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Dicot Pharma AB share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Dicot Pharma AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dicot Pharma AB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +53.71%.
As of the last closing price of SEK0.34, shares in Dicot Pharma AB were trading +45.91% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Dicot Pharma AB PE Ratio?
The Dicot Pharma AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.34.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Dicot Pharma AB?
We do not have data on Dicot Pharma AB's directors